109 related articles for article (PubMed ID: 8201680)
1. Nephrocalcin in patients with renal cell carcinoma.
Nakagawa Y; Netzer M; Michaels EK; Suzuki F; Ito H
J Urol; 1994 Jul; 152(1):29-34. PubMed ID: 8201680
[TBL] [Abstract][Full Text] [Related]
2. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo.
Nakagawa Y; Sirivongs D; Novy MB; Netzer MF; Michaels E; Vogelzang NJ; Coe FL
Cancer Res; 1992 Mar; 52(6):1573-9. PubMed ID: 1540966
[TBL] [Abstract][Full Text] [Related]
3. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
Nakagawa Y
Keio J Med; 1997 Mar; 46(1):1-9. PubMed ID: 9095576
[TBL] [Abstract][Full Text] [Related]
4. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.
Nakagawa Y; Otsuki T; Coe FL
FEBS Lett; 1989 Jul; 250(2):187-90. PubMed ID: 2753126
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of nephrocalcin, a kidney-specific glycoprotein, to renal cell carcinoma.
Michaels EK; Ghosh L; Nakagawa Y; Netzer MF; Vidal P; Arsenault D; Ito H
Urology; 1998 Nov; 52(5):920-4. PubMed ID: 9801131
[TBL] [Abstract][Full Text] [Related]
7. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
Coe FL; Nakagawa Y; Asplin J; Parks JH
Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
[TBL] [Abstract][Full Text] [Related]
8. Evidence that mouse renal proximal tubule cells produce nephrocalcin.
Sirivongs D; Nakagawa Y; Vishny WK; Favus MJ; Coe FL
Am J Physiol; 1989 Sep; 257(3 Pt 2):F390-8. PubMed ID: 2782421
[TBL] [Abstract][Full Text] [Related]
9. Protein inhibitors of crystal growth.
Kaiser ET; Bock SC
J Urol; 1989 Mar; 141(3 Pt 2):750-2. PubMed ID: 2645434
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
11. Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.
Deganello S
Calcif Tissue Int; 1991 Jun; 48(6):421-8. PubMed ID: 2070277
[TBL] [Abstract][Full Text] [Related]
12. Defective urinary crystallization inhibition and urinary stone formation.
Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
[TBL] [Abstract][Full Text] [Related]
13. FKBP-12 exhibits an inhibitory activity on calcium oxalate crystal growth in vitro.
Han IS; Nakagawa Y; Park JW; Suh MH; Suh SI; Shin SW; Ahn SY; Choe BK
J Korean Med Sci; 2002 Feb; 17(1):41-8. PubMed ID: 11850587
[TBL] [Abstract][Full Text] [Related]
14. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
Asplin J; DeGanello S; Nakagawa YN; Coe FL
Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
[TBL] [Abstract][Full Text] [Related]
15. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine.
Nakagawa Y; Abram V; Coe FL
Am J Physiol; 1984 Nov; 247(5 Pt 2):F765-72. PubMed ID: 6496744
[TBL] [Abstract][Full Text] [Related]
16. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
[TBL] [Abstract][Full Text] [Related]
17. Isolation of nephrocalcin from kidney tissue of nine vertebrate species.
Nakagawa Y; Renz CL; Ahmed M; Coe FL
Am J Physiol; 1991 Feb; 260(2 Pt 2):F243-8. PubMed ID: 1996674
[TBL] [Abstract][Full Text] [Related]
18. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.
Worcester EM; Sebastian JL; Hiatt JG; Beshensky AM; Sadowski JA
Calcif Tissue Int; 1993 Oct; 53(4):242-8. PubMed ID: 8275352
[TBL] [Abstract][Full Text] [Related]
19. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
Hess B
Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
[TBL] [Abstract][Full Text] [Related]
20. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
